Enesi’s ImplaVax^® enabled products have transformational potential for patients, users and suppliers, including:

• Multiple products formulated with excellent stability profiles – up to two-years’ stability demonstrated
• Enhanced immune response for vaccines demonstrated compared to standard injection
• Direct needle-free solid dose delivery – rapid administration, easy and intuitive to use for one-off and repeat-use regimens
• Strong patient preference for ImplaVax^® over needle and syringe
• Single-use disposable cassettes – eliminating risk of disease transmission between individuals from shared needles
• No need to dispose of hazardous needles, syringes or vials eliminating needle stick injuries for patients and care givers, and reducing costs associated with disposal
• No need for additional diluents or water for reconstitution at point of care
• Single unitary dose – 100% dosing assured each time
• Reducing/eliminating need for cold-chain requirements